Takeda Millennium

Business briefs: Eli Lilly, Millennium/Takeda, Elan

Eli Lilly nixes one trial and fails another; Millennium is folded into Takeda, Dunsire retires; Elan pays for Theravance royalties in attempt to avoid takeover.

Email Newsletters

MM&M inVISION